Delivery Order SPE2DB22D3301-SPE2DB25FX8VR
Award Date
1/22/25
Potential Completion Date
1/23/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,299.84, is for the delivery of 4566817262 TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of January 2, 2025 and was awarded on December 31, 2024. This contract is a delivery order under an Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DB20D3101|SPE2DB25FRAL4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,369.91, is a Firm Fixed Price Delivery Order for the provision of 4567101009 - TELMISARTAN 80 MG TABLET 30S. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award, with ID SPE2DB22D2005|SPE2DB25FJHV9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication, with a ceiling value of $4,959.21. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of February 25, 2025. This award is not...
This federal contract award, valued at $2,494.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567058573 - TELMISARTAN 80 MG TABLET 30S, a pharmaceutical product, with a performance period ending on January 28, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award, valued at $1,424.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999, is for the supply of TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication, to support military healthcare programs. This contract does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,589.82 firm fixed-price delivery order is for the supply of 4566680655 - TELMISARTAN 80 MG TABLET 30S, with a performance period ending on December 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,004.26 firm-fixed-price delivery order is for the supply of 4563134465 TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication, with a completion date of December 19, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,674.67, is a delivery order for the supply of 4565040739 - TELMISARTAN 40 MG TABLET 30S. The contract has an ultimate completion date of July 2, 2024 and is a firm fixed price contract. Amerisourcebergen Drug Corp is the prime contractor and there is no indication of any set-aside...
This federal contract award, valued at $1,077.45, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The award covers the delivery of TELMISARTAN 80 MG TABLET 30S, a pharmaceutical product, with an ultimate completion date of October 22, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
This federal contract award to Amerisourcebergen Drug Corp is a firm fixed-price delivery order from the Defense Logistics Agency (DLA) for 4566554653 - TELMISARTAN 80 MG TABLET 30S. The contract has a ceiling value of $1,455.66 and a completion date of November 27, 2024. This is not a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, including the military and veterans'...